论文部分内容阅读
随着剖宫产率增高,产褥期发生化脓性炎症并发症的风险增加。为研究应用臭氧疗法预防剖宫产后妇女发生化脓性炎症并发症的可行性,30例有发病高度风险的剖宫产术后妇女纳入研究。全部产妇于妊娠38～39周时在分娩活动开始前行子宫下段横切口计划剖宫产术。在剖宫产术后第1d开始每日静滴用臭氧处理过的0.9％氯化钠溶液(臭氧浓度4mg/L)400ml,5d为1疗程。产后1～5d研究血液临床检验参数和生化指示,包括检测血清中分子(MWM),可溶于酸的核酸部分(AFNA)、同硫巴比土酸相互作用的活性产物(TBA-AP)。
As the cesarean section rate increases, the risk of complications of purulent inflammation in the puerperium increases. To study the feasibility of using ozone therapy to prevent the complications of suppurative inflammation in women after cesarean section, 30 women with high risk of cesarean section were included in the study. All mothers in the 38 to 39 weeks of pregnancy at the beginning of labor activities before the lower uterine incision planned cesarean section. In cesarean section after the first day of intravenous infusion of 0.9% sodium chloride solution (ozone concentration 4mg / L) 400ml, 5d for a course of treatment. Clinical parameters and biochemical indicators of blood tests were studied 1 to 5 days postpartum, including detection of serum molecular weight (MWM), acid-soluble nucleic acid fraction (AFNA), and active product of thiobarbituric acid interaction (TBA-AP).